Are fibrocytes present in pediatric burn wounds?

Journal of Burn Care and Research

Volumn 29, Issue 4, 2008, Pages 619-626

  Holland, Andrew J A ^a   Tarran, Sarah L S ^b   Medbury, Heather J ^b   Guiffre, Ann K ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIBODY; CELL PROTEIN; LEUKOCYTE PROTEIN 1; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ACTIN; CD34 ANTIGEN; COLLAGEN TYPE 1; LST1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADOLESCENT; ARTICLE; BURN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEBRIDEMENT; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFANT; LEUKOCYTE FUNCTION; PRESCHOOL CHILD; PROTEIN ANALYSIS; PUNCH BIOPSY; SCAR FORMATION; SCHOOL CHILD; SKIN HYPERTROPHY; STAINING; WOUND; BIOPSY; METABOLISM; PATHOLOGY; PROSPECTIVE STUDY;

ACTINS; ADOLESCENT; ANTIGENS, CD34; BIOPSY; BURNS; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE I; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MEMBRANE PROTEINS; PROSPECTIVE STUDIES;

EID: 56149119655     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e31817db90a     Document Type: Article

References (27)

1. Sheridan RL. Burns. Crit Care Med 2002;30:S500-S514.
2. Blakeney PE, McCauley RL, Herndon DN. Prolonged hypermetabolic response over time, the use of anabolic agents and exercise, and longitudinal evaluation of the burned child. In: Herndon D, editor. Total burn care. London: Saunders; 2002. p. 611-619.
3. Griffiths HR, Thornton KL, Clements CM, Burge TS, Kay AR, Young AER. The cost of a hot drink scald. Burns 2006; 32:372-374.
4. Zeitlin REK, Jarnberg J, Somppi EJ, et al. Long-term functional sequelae after paediatric burns. Burns 1998;24:3-6.
5. Nguyen NL, Gun RT, Sparnon AL, et al. The importance of immediate cooling-a case series of childhood burns in Vietnam. Burns 2002;28:173-176.
6. Klein MB, Silver G, Gamelli RL, et al. Inflammation and the host response to injury: an overview of the multicenter study of the genomic and proteomic response to burn injury. J Burn Care Res 2006;27:448-451.
7. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994;1:71-81.
8. Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001;166:7556-7562.
9. Hartlapp I, Abe R, Saeed RW, et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001;15:2215-2224.
10. Quan TE, Cowper S, Wu SP, et al. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004;36:598-606.
11. Yang L, Scott PG, Dodd C, et al. Identification of fibrocytes in postburn hypertrophic scar. Wound Repair Regen 2005; 13:398-404.
12. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870.
13. Yang L, Scott PG, Giuffre J, et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002;82:1183-1192.
14. Ghahary A, Shen YJ, Scott PG, et al. Enhanced expression of mRNA for transforming growth factor-B, type I and type III procollagen in human post-burn hypertrophic scar tissues. J Lab Clin Med 1993;122:465-473.
15. Wang JF, Wu Y, Medina A, et al. The role of fibrocytes in post-burn hypertrophic scarring. In: Bucala R, editor. Fibrocytes: new insights into tissue repair and systemic fibroses. World Scientific Publishing Co. Pte. Ltd: Singapore; 2007. p. 75-104.
16. Holland AJA, Martin HCO, Cass DT. Laser Doppler imaging prediction of burn wound outcome in children. Burns 2002;28:11-17.
17. Mori L, Bellini A, Stacey MA, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Eye Res 2005;304:81-90.
18. Varcoe RL, Mikhail M, Guiffre AK, et al. The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost 2006;4: 1125-1133.
19. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrowderived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007;87:858-870.
20. Barth PJ, Ebrahimsade S, Hellinger A, et al. CD34- fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 2002;440:128-133.
21. Schmidt M, Sun G, Stacey MA, et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003;171:380-389.
22. Santucci M, Borgognoni L, Reali Uea. Keloids and hypertrophic scars of Caucasians show distinctive morphologic and immunophenotypic profiles. Virchows Arch 2001;457-463.
23. Aiba S, Tagami H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutan Pathol 1997;24:65-69.
24. Chesney J, Metz CN, Stavitsky AB, et al. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998;160:419-425.
25. Matsumura H, Engrav L, Gibran NS, et al. Cones of skin occur where hypertrophic scar occurs. Wound Repair Regen 2001;9:269-277.
26. Stewart CJ, Frank R, Forrester KR, et al. A comparison of two laser-based methods for determination of burn scar perfusion: laser Doppler versus laser speckle imaging. Burns 2005;31: 744-752.
27. Demetriou M, Binkert C, Sukhu B, et al. Fetuin/á2-HS Glycoprotein is a transforming growth factor-a type II receptor mimic and cytokine antagonist. J Biol Chem 1996;271: 12755-12761.